Blog
The drug discovery industry is evolving rapidly, and the business is expected to reach USD 27.23 billion in 2030 with a significant CAGR of 10.7%. Therefore, the life sciences industry...
Artificial intelligence (AI) technology will provide new levels of productivity and insight. But when it comes to regulated laboratory environments, such as those that must meet Food and Drug Administration...
As modern laboratories are entering a decisive shift toward true operational intelligence, Agentic AI represents a future unlike past AI and task-based simple automation waves by introducing autonomous, context-aware agents...
A glimpse into the future with Agentic AI Modern labs and R&D are entering a decisive shift towards true operational intelligence defined by autonomy, speed, and adaptability. With the increasing...
Advanced labs are the bedrock of science progression. Yet they’re routinely hampered by the inefficiencies created by disparate digital systems. Electronic laboratory notebooks (ELN), laboratory execution systems (LES), and laboratory...
Reagent Lifecycle 2.0: Why Leading Bioanalytical Labs Are Standardizing on Integrated LIMS & ELN Platforms In modern bioanalytical labs, reagents are no longer “consumables in the background”. They are data-bearing...
With the rapidly changing R&D environment of today, formulation scientists are racing against the clock for faster innovation, better-performing products, and sustainable alternatives. Many teams are still navigating development through...
In today’s pharmaceutical landscape, the path from target discovery to market-ready drug is long, risky, and expensive, taking on average 10–12 years and costing billions. More than nine out of...
